Skip to main content
. 2023 Jan 8;15(2):418. doi: 10.3390/cancers15020418

Figure 2.

Figure 2

The impact of Immunoscore on MSS patients with Stage II colon cancer. Kaplan-Meier curves of Immunoscore (I) two categories: Lo (0–25%, black) and Int+Hi (>25–100%, red) are shown for TTR (A,E) and DFS (B,F). (A–D) Stage II MSS patients from cohorts 1 and 2. (E,F) Untreated Stage II T4N0 patients from cohorts 1 and 2. Relative importance of each risk parameter to survival risk for TTR (C) and DFS (D) using the χ2 proportion test for clinical parameters and Immunoscore corresponding to panels A, B. Significant logrank p-values are marked as *** p < 0.001.